Hope S. Rugo, MD, FASCO, outlined the top considerations for nurses managing toxicities related to PI3K and AKT inhibitors in ...

Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T-cell engagers, ...

Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple ...

Nurses should be familiar with PET scan protocol and what to ask patients with lung and bone cancers before administering ...

Given these data, Kirschner, the director of program development at the Cancer Survivorship and Supportive Care Professionals ...

New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.

Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and ...

Experienced oncology nurses and APPs can help nurses newer to the field understand who is more at risk of opioid addiction, ...

Panelists discuss how the unprecedented 5-year progression-free survival benefit (60% vs 8%) demonstrated in the CROWN trial ...

Establishing a routine early in treatment helps proactively manage adverse effects associated with CDK4/6 inhibitors, says ...

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell ...